Daxor Corporation (NASDAQ: DXR)
$8.2900
-0.0099 ( +3.63% ) 5.0K
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.
Market Data
Open
$8.2900
Previous close
$8.2999
Volume
5.0K
Market cap
$38.72M
Day range
$7.9550 - $8.1850
52 week range
$7.1900 - $10.0400
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Dec 10, 2024 |
4 | Insider transactions | 1 | Dec 10, 2024 |
4 | Insider transactions | 1 | Dec 10, 2024 |
nport-p | Other | 1 | Nov 21, 2024 |
n-px | Other | 2 | Sep 10, 2024 |
n-csrs | Other | 3 | Aug 29, 2024 |
nport-p | Other | 1 | Aug 29, 2024 |
8-k | 8K-related | 14 | Jul 18, 2024 |
4 | Insider transactions | 1 | Jul 17, 2024 |
4 | Insider transactions | 1 | Jul 17, 2024 |